p53 gene mutations are associated with rapid progression and poor survival in low and low-intermediate risk diffuse large B-cell lymphomas.: A gela study.

被引：0
|
作者：
Leroy, K [1 ]
Haioun, C [1 ]
Lapage, E [1 ]
Le Métayer, N [1 ]
Berger, F [1 ]
Labouyrie, E [1 ]
Duval, C [1 ]
Meignin, V [1 ]
Petit, B [1 ]
Bastard, C [1 ]
Salles, G [1 ]
Gisselbrecht, C [1 ]
Reyes, F [1 ]
Gaulard, P [1 ]
机构：
[1] Hop Henri Mondor AP HP, Dept Pathol & EA2348, F-94010 Creteil, France
来源：
BLOOD | 1999年 / 94卷 / 10期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
3090
引用
收藏
页码：699A / 699A
页数：1
相关论文
共 43 条
  • [21] NF-κB p50 activation associated with immune dysregulation confers poorer survival for diffuse large B-cell lymphoma patients with wild-type p53
    Cai, Qingqing
    Tu, Meifeng
    Xu-Monette, Zijun Y.
    Sun, Ruifang
    Manyam, Ganiraju C.
    Xu, Xiaolu
    Tzankov, Alexander
    Hsi, Eric D.
    Moller, Michael B.
    Medeiros, L. Jeffrey
    Ok, Chi Young
    Young, Ken H.
    MODERN PATHOLOGY, 2017, 30 (06) : 854 - 876
  • [22] Autologous stem cell transplantation (ASCT) as consolidation therapy for patients with low-intermediate (LI) risk diffuse large B-cell lymphoma (DLBCL) and overexpression of bcl2 protein.: Results of the first interim analysis of the GELA trial LNH98-B2.
    Morel, P
    Mounier, N
    Brière, J
    Ferme, C
    Coiffier, B
    Tilly, H
    Gaulard, P
    Lederlin, P
    Reyes, F
    Gisselbrecht, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 559S - 559S
  • [23] Low Total T-cell Content and Low PD1-Positive T-cells Identified by Multiplex Immunofluorescence is Associated with Poor Survival in Diffuse Large B-cell Lymphoma
    Meawad, Hany
    Herrera, Alex
    Nwangwu, Mary
    He, Ting-Fang
    Bedell, Victoria
    Murata-Collins, Joyce
    Pillai, Raju
    Perry, Anamarija
    Weisenburger, Dennis
    Song, Joo
    LABORATORY INVESTIGATION, 2021, 101 (SUPPL 1) : 875 - 876
  • [24] Low Total T-cell Content and Low PD1-Positive T-cells Identified by Multiplex Immunofluorescence is Associated with Poor Survival in Diffuse Large B-cell Lymphoma
    Meawad, Hany
    Herrera, Alex
    Nwangwu, Mary
    He, Ting-Fang
    Bedell, Victoria
    Murata-Collins, Joyce
    Pillai, Raju
    Perry, Anamarija
    Weisenburger, Dennis
    Song, Joo
    MODERN PATHOLOGY, 2021, 34 (SUPPL 2) : 875 - 876
  • [25] Low expression of p27 protein combined with altered p53 and Rb/p16 expression status is associated with increased expression of cyclin A and cyclin B1 in diffuse large B-cell lymphomas (vol 14, pg 1105, 2001)
    Kanavaros, P
    MODERN PATHOLOGY, 2002, 15 (04) : 475 - 475
  • [26] Low Blood Absolute CD4 Counts Is Associated with Inferior Progression Free Survival in Diffuse Large B-Cell Lymphoma Independent of Age and IPI
    Al-Saleem, Tahseen I.
    Dulaimi, Essel
    Millenson, Michael M.
    Smith, Mitchell R.
    Judd, Julia
    Li, Tianyu
    Borghaei, Hossein
    BLOOD, 2014, 124 (21)
  • [27] Expression of TNF-receptor associated factor 2 correlates with poor progression-free survival time in ABC-like primary nodal diffuse large B-cell lymphomas
    van Galen, J. C.
    Muris, J. J. F.
    Giroth, C. P. E.
    Vos, W.
    Ossenkoppele, G. J.
    Meijer, C. J. L. M.
    Oudejans, J. J.
    HISTOPATHOLOGY, 2008, 52 (05) : 578 - 584
  • [28] The Pathogenomic Landscape of Diffuse Large B-Cell Lymphomas (DLBCL) Reveals That MYC/TP53 Coexpression and Loss of 17p13 Are Independently Associated With Inferior Survival
    Ma, Charles
    Thodima, Venkata
    Xie, Yi
    Tulpule, Anil
    Desai, Kshijita
    Sidoti, Hannah
    Caviasco, Christina
    Siddiqi, Imran
    Houldsworth, Jane
    MODERN PATHOLOGY, 2015, 28 : 361A - 362A
  • [29] The Pathogenomic Landscape of Diffuse Large B-Cell Lymphomas (DLBCL) Reveals That MYC/TP53 Coexpression and Loss of 17p13 Are Independently Associated With Inferior Survival
    Ma, Charles
    Thodima, Venkata
    Tulpule, Anil
    Desai, Kshijita
    Sidoti, Hannah
    Caviasco, Christina
    Siddiqi, Imran
    Houldsworth, Jane
    LABORATORY INVESTIGATION, 2015, 95 : 361A - 362A
  • [30] Mutations in the DNA-binding codons of TP53, which are associated with decreased expression of TRAIL receptor-2, predict for poor survival in diffuse large B-cell lymphoma
    Young, Ken H.
    Weisenburger, Dennis D.
    Dave, Bhavana J.
    Smith, Lynette
    Sanger, Warren
    Iqbal, Javeed
    Campo, Elias
    Delabie, Jan
    Gascoyne, Randy D.
    Ott, German
    Rimsza, Lisa
    Mueller-Hermelink, H. Konrad
    Jaffe, Elaine S.
    Rosenwald, Andreas
    Staudt, Louis M.
    Chan, Wing C.
    Greiner, Timothy C.
    BLOOD, 2007, 110 (13) : 4396 - 4405
12345